以磁共振成像质子密度脂肪分数为参考标准,前瞻性评估超声衰减成像在慢性肝病患者肝脂肪变性中的诊断价值
前瞻性分析87例同时具有可靠超声衰减成像(ATI)和磁共振质子密度脂肪分数(MRI-PDFF)测量的慢性肝病患者,评估ATI诊断肝脂肪变性的效能。ATI诊断MRI-PDFF≥5%和≥10%的AUC分别为0.76和0.88,衰减系数与MRI-PDFF中度相关(ρ=0.66)。结论认为ATI衰减系数与MRI-PDFF相关性好,可能为肝脂肪变性的无创评估与定量提供良好诊断效能。
要点
- ATI诊断MRI-PDFF≥5%肝脂肪变性的AUC为0.76(95%CI 0.66-0.85)。
- ATI诊断MRI-PDFF≥10%肝脂肪变性的AUC为0.88(95%CI 0.79-0.94)。
- ATI衰减系数与MRI-PDFF中度相关(ρ=0.66)。
核心结论
- 超声ATI衰减系数与MRI-PDFF相关性好,可能对肝脂肪变性提供良好诊断效能,是有前景的无创评估与定量工具。
研究设计与样本
- 前瞻性研究,纳入87例同时具有可靠ATI和MRI-PDFF测量的慢性肝病患者,以MRI-PDFF为参考标准。
诊断标准与关键数值
- ATI诊断MRI-PDFF≥5%肝脂肪变性的AUC为0.76(95%CI 0.66-0.85)。
- ATI诊断MRI-PDFF≥10%肝脂肪变性的AUC为0.88(95%CI 0.79-0.94)。
- ATI衰减系数与MRI-PDFF的相关系数ρ=0.66。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
The purpose of our study was to investigate the diagnostic performance of 2-D ultrasound attenuation imaging (ATI) for the assessment of hepatic steatosis in patients with chronic liver disease using magnetic resonance imaging proton density fat fraction (MRI-PDFF) as the reference standard. We prospectively analyzed 87 patients with chronic liver disease who had reliable measurements at both ATI and MRI-PDFF. For the detection of hepatic steatosis of MRI-PDFF ≥5% and MRI-PDFF ≥10%, ATI measurements yielded areas under the receiver operating characteristic curve of 0.76 and 0.88, respectively (95% confidence intervals: 0.66-0.85 and 0.79-0.94). Attenuation coefficients at ATI were moderately correlated with MRI-PDFF (ρ = 0.66). In conclusion, attenuation coefficients at ultrasound ATI were well correlated with MRI-PDFF and, thus, may provide good diagnostic performance in the assessment of hepatic steatosis, making these coefficients a promising tool for the non-invasive assessment and quantification of hepatic steatosis.
引用
- Jeon SK, Lee JM, Joo I, et al. Prospective Evaluation of Hepatic Steatosis Using Ultrasound Attenuation Imaging in Patients with Chronic Liver Disease with Magnetic Resonance Imaging Proton Density Fat Fraction as the Reference Standard. Ultrasound Med Biol. 2019. PMID: 30975533. doi:10.1016/j.ultrasmedbio.2019.02.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。